RxNorm 1729013 NDC Crossover

Uptravi 1000 MCG Oral Tablet

Related NDC Codes to RxNorm Concept 1729013

The following NDC codes crossover to the RxNorm Concept 1729013. This list is useful when crossing over from a given RxNorm code and the user is trying to choose a drug or product included in the NDC directory.

NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Labeler Name	Status
66215-602	Uptravi	Selexipag	Tablet, Coated	Oral	Actelion Pharmaceuticals Us, Inc.	ACTIVE
66215-604	Uptravi	Selexipag	Tablet, Coated	Oral	Actelion Pharmaceuticals Us, Inc.	ACTIVE
66215-606	Uptravi	Selexipag	Tablet, Coated	Oral	Actelion Pharmaceuticals Us, Inc.	ACTIVE
66215-608	Uptravi	Selexipag	Tablet, Coated	Oral	Actelion Pharmaceuticals Us, Inc.	ACTIVE
66215-610	Uptravi	Selexipag	Tablet, Coated	Oral	Actelion Pharmaceuticals Us, Inc.	ACTIVE
66215-612	Uptravi	Selexipag	Tablet, Coated	Oral	Actelion Pharmaceuticals Us, Inc.	ACTIVE
66215-614	Uptravi	Selexipag	Tablet, Coated	Oral	Actelion Pharmaceuticals Us, Inc.	ACTIVE
66215-616	Uptravi	Selexipag	Tablet, Coated	Oral	Actelion Pharmaceuticals Us, Inc.	ACTIVE
66215-628	Uptravi Titration Pack	Selexipag	Kit		Actelion Pharmaceuticals Us, Inc.	ACTIVE
66215-718	Uptravi	Selexipag	Injection, Powder, For Solution	Intravenous	Actelion Pharmaceuticals Us, Inc.	ACTIVE